JP2012511506A5 - - Google Patents

Download PDF

Info

Publication number
JP2012511506A5
JP2012511506A5 JP2011539029A JP2011539029A JP2012511506A5 JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5 JP 2011539029 A JP2011539029 A JP 2011539029A JP 2011539029 A JP2011539029 A JP 2011539029A JP 2012511506 A5 JP2012511506 A5 JP 2012511506A5
Authority
JP
Japan
Prior art keywords
human insulin
desb30
insulin
amino acid
analogue
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2011539029A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012511506A (ja
Filing date
Publication date
Priority claimed from PCT/EP2009/053017 external-priority patent/WO2009115469A1/en
Application filed filed Critical
Priority claimed from PCT/EP2009/066335 external-priority patent/WO2010066636A1/en
Publication of JP2012511506A publication Critical patent/JP2012511506A/ja
Publication of JP2012511506A5 publication Critical patent/JP2012511506A5/ja
Withdrawn legal-status Critical Current

Links

JP2011539029A 2008-12-09 2009-12-03 新規インスリンアナログ Withdrawn JP2012511506A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
EP08171086 2008-12-09
EP08171086.5 2008-12-09
EPPCT/EP2009/053017 2009-03-13
PCT/EP2009/053017 WO2009115469A1 (en) 2008-03-18 2009-03-13 Protease stabilized, acylated insulin analogues
EP09161014.7 2009-05-25
EP09161014 2009-05-25
EP09161232.5 2009-05-27
EP09161232 2009-05-27
PCT/EP2009/066335 WO2010066636A1 (en) 2008-12-09 2009-12-03 Novel insulin analogues

Publications (2)

Publication Number Publication Date
JP2012511506A JP2012511506A (ja) 2012-05-24
JP2012511506A5 true JP2012511506A5 (https=) 2014-06-19

Family

ID=41651437

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011539029A Withdrawn JP2012511506A (ja) 2008-12-09 2009-12-03 新規インスリンアナログ

Country Status (5)

Country Link
US (1) US20110294729A1 (https=)
EP (1) EP2376531A1 (https=)
JP (1) JP2012511506A (https=)
CN (1) CN102245633A (https=)
WO (1) WO2010066636A1 (https=)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE032284T2 (en) 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues
KR20130036290A (ko) 2010-06-23 2013-04-11 노보 노르디스크 에이/에스 추가 이황화 결합을 함유하는 인슐린 유도체
WO2011161083A1 (en) 2010-06-23 2011-12-29 Novo Nordisk A/S Human insulin containing additional disulfide bonds
JP5973427B2 (ja) * 2010-06-23 2016-08-23 ノヴォ ノルディスク アー/エス 追加のジスルフィド結合を含有するインスリン類似体
CN104364260B (zh) 2012-04-11 2017-02-22 诺和诺德股份有限公司 胰岛素制剂
US20150198619A1 (en) * 2012-09-25 2015-07-16 The Walter And Eliza Hall Institute Of Medical Research Structure of insulin in complex with n- and c-terminal regions of the insulin receptor alpha-chain
US20140269611A1 (en) * 2013-03-14 2014-09-18 T-Mobile Usa, Inc. Communication Handovers from Networks Using Unlicensed Spectrum to Circuit-Switched Networks
BR112019000991A2 (pt) 2016-07-22 2019-07-02 University Of Utah Research Foundation análogo da insulina, composição farmacêutica, método para tratar e/ou prevenir uma afeção relacionada com insulina, método para decrescer níveis de glicose no sangue, uso do análogo da insulina, método de replanejamento ou modificação de um polipeptídeo que é conhecido por se ligar a um receptor da insulina, polipeptídeo, molécula isolada, método para identificar um composto que se liga ao receptor de insulina, método de base computacional para identificar um composto que imita a atividade da insulina, composto identificado usando um método, cristal do polipeptídeo, estrutura do polipeptídeo, uso da estrutura, uso do modelo estrutural, peptídeo, método para aumentar a ativação do receptor da insulina em um sujeito, método para diminuir o açúcar no sangue em um sujeito, método para tratar diabetes tipo 1 em um sujeito e proteína terapêutica
PE20210857A1 (es) 2016-12-16 2021-05-18 Novo Nordisk As Composiciones farmaceuticas que contienen insulina
KR20210102347A (ko) 2018-12-11 2021-08-19 사노피 인슐린 수용체 결합 친화성이 감소된 인슐린 유사체

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH03506023A (ja) * 1988-07-20 1991-12-26 ノボ ノルデイスク アクツイエセルスカプ ポリペプチド
US5716927A (en) * 1988-12-23 1998-02-10 Novo Nordisk A/S Insulin analogs having a modified B-chain
HU210142B (en) * 1989-04-20 1995-02-28 Sinai School Medicine Process for producing hepatospecific insulin-analogues and pharmaceutical compositions containing them
US5268453A (en) * 1991-08-08 1993-12-07 Scios Inc. Tissue-selective insulin analogs
CA2372393A1 (en) * 1999-05-19 2000-11-23 Bassil I. Dahiyat Novel proteins with insulin-like activity useful in the treatment of diabetes
US6746853B1 (en) * 1999-05-19 2004-06-08 Xencor, Inc. Proteins with insulin-like activity useful in the treatment of diabetes
RU2524150C2 (ru) * 2006-09-22 2014-07-27 Ново Нордиск А/С Аналоги инсулина, устойчивые к протеазам
WO2009112583A2 (en) * 2008-03-14 2009-09-17 Novo Nordisk A/S Protease-stabilized insulin analogues
HUE032284T2 (en) * 2008-03-18 2017-09-28 Novo Nordisk As Protease-stabilized, acylated insulin analogues

Similar Documents

Publication Publication Date Title
JP2012511506A5 (https=)
WO2014071405A3 (en) Long-acting single-chain insulin analogues
JP2013530974A5 (https=)
MY158627A (en) Halogen-stabilized insulin
JP2018505146A5 (https=)
JP2014129355A5 (https=)
EP2543727A4 (en) MODIFIED ANTIBODY COMPOSITION
WO2013002580A3 (ko) 폴리에틸렌글라이콜 또는 이의 유도체로 페길화된 엑센딘-4 유사체, 이의 제조방법 및 이를 유효성분으로 함유하는 당뇨병 예방 또는 치료용 약학적 조성물
Gonçalves et al. Denture adhesives improve mastication in denture wearers
WO2015128403A3 (en) An a22k, desb27, b29r, des b30, at epsilon position of lysine 22 acylated human insulin analogue
MX354705B (es) Analogos de glucagon novedosos.
JP2013530702A5 (https=)
MX2013011175A (es) Analogos de glucagon novedosos.
JP2013542919A5 (https=)
WO2011080102A3 (en) Glp-1 analogues and derivatives
EP2581389A4 (en) FUSION PROTEIN FROM EXENDIN-4 AND ANALOG FROM THIS AND THE PRODUCTION PROCESS THEREFOR AND USE THEREOF
CA2729938A1 (en) New insulin analogues of prolonged activity
EP2570873A3 (en) Watch with shapeable strap
WO2015055802A3 (en) Glucagon analogues
HK1200369A1 (en) Glucagon analogues
WO2011072288A3 (en) Insulin analogues with chlorinated amino acids
RU2012157683A (ru) Производные инсулина, содержащие дополнительные дисульфидные связи
RU2018107727A (ru) Новые производные инсулина и их медицинские применения
WO2014195966A3 (en) Amorphous form of canagliflozin and process for preparing thereof
WO2016105545A3 (en) Insulin analogues with enhanced stabilized and reduced mitogenicity